Please login to read the full article.
Scrip Regulatory Affairs
US FDA considers new labelling policy for home-use devices
23 April 2010
Vibha Sharma, Bernard Murphy
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US bill proposes conditional clearance authority for FDA's 510(k) process
- US FDA action on drug shortages yields results, agency improves user fee goals
- US bill asks FDA to issue final UDI rule by 2012-end and expand Sentinel monitoring to devices
- GHTF successor IMDRF to expand membership; shortlists work priorities at inaugural meeting
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
